$0.00
(0.00%)
| Today's Open | $73.84 |
|---|---|
| Previous Close | $74.16 |
| Daily Range | $73.76 - $74.82 |
| 52-Week Range | $51.20 - $75.67 |
| Market Cap | $183.4B |
| P/E Ratio | 19.06 |
| Dividend (Yield) | $2.53 (2.8%) |
| Ex-Dividend Date Dividend Pay Date |
02/26/13 04/05/13 |
| Volume | 1,520,788 |
| Average Daily Volume | 1,442,698 |
| Current FY EPS | $5.11 |
Sector
Healthcare
Industry
Drugs
Novartis (NVS) Description
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/
News & Commentary
Share are up so far in 2013, but how does Pfizer stock look now? Find out in this month's stock checkup.
Positive Data on Novartis' Afinitor - Analyst Blog
Positive Data on Novartis' Afinitor - Analyst BlogNew data reinforces strength of Novartis once-daily COPD portfolio in improving lung function, short
New data reinforces strength of Novartis once-daily COPD portfolio in improving lung function, shortness of breath and reducing rate of exacerbationsJohnson & Johnson Stock Checkup for May
With shares on a steady rise so far in 2013, how does Johnson & Johnson stock look now? Find out in this month's stock checkup.Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started
Biogen's MS drug is off to a hot start, and its new hemophilia drugs are under FDA review.The 5 Richest Countries in the World
These five countries from four different regions have populations that enjoy the benefits of a strong economy.NVS's Top Competitors
(0.63%)
(0.66%)
(4.69%)
(0.84%)